J2P-MC-LXBD app for iPhone and iPad
4.4 (
6624 ratings )
Health & Fitness
Medical
Developer: Medable, Inc.
Free
Current version: 1.1, last update: 4 months agoFirst release : 20 Sep 2023
App size: 86.7 Mb
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain